Cell-Free DNA Chromatin Immunoprecipitation (ChIP) for Diagnosing Cancer

Recruiting now

Conditions studied: Cancer of Pancreas

In brief

The goal of this research is to use chromatin immunoprecipitation, a method used to study protein-DNA interaction, as a tool to diagnose and prognose pancreatic ductal adenocarcinoma in human samples. This is a Non-Human Subject Research study. All participants are de-identified.

Key facts

Study ID

NCT06148298

Run by

University of Central Florida

People needed

24

Starts

2023-05-24

Expected to finish

2025-05-01

Last updated by the study team

2024-12-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 18 years old or older
• Pancreatic cancer patients

You may not qualify if…

• Children may not register
• Persons who are unable to consent may not register

Where it is running

• University of Central Florida — Orlando, Florida, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.